Resolution of Gastroparesis Symptoms With the Removal of a Dipeptidyl Peptidase-4 Inhibitor

被引：0
|
作者：
Nuvvula, Sri [1 ]
Rau, Prashanth [2 ]
Belkin, Dimitri [2 ]
Houghton, Jean Marie [1 ]
机构：
[1] Univ Massachusetts, Med Sch, Worcester, MA USA
[2] Univ Massachusetts, Med Ctr, Worcester, MA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S3125
引用
收藏
页码：S1289 / S1289
页数：1
相关论文
共 50 条
  • [31] The Effect of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin on Gentamicin Nephrotoxicity in Mice
    Ali, Badreldin H.
    Suleimani, Yousuf M.
    Abdelrahman, Aly M.
    Karaca, Turan
    Nemmar, Abderrahim
    FASEB JOURNAL, 2018, 32 (01):
  • [32] Dipeptidyl peptidase-4 inhibitors and osteoporosis
    Lee, Wen-Ling
    Lee, Fa-Kung
    Wang, Peng-Hui
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2022, 85 (09) : 889 - 890
  • [33] Reduced Burden of Hypoglycemia Related to Dipeptidyl Peptidase-4 Inhibitor Use
    Liu, Jinan
    Tang, Yuexin
    Rajpathak, Swapnil
    Engel, Samuel
    Hannachi, Hakima
    DIABETES, 2017, 66 : LB1 - LB1
  • [34] The role of dipeptidyl peptidase-4 inhibitors
    Lasserson, Daniel
    Mant, Jonathan
    BRITISH MEDICAL JOURNAL, 2012, 344
  • [35] Effects of dipeptidyl peptidase-4 inhibition in vivo: Dipeptidyl peptidase-4 inhibitor/gut microbiome crosstalk suggests novel therapeutic options for diabetes management
    Yasuda, Takuma
    Harada, Norio
    Inagaki, Nobuya
    JOURNAL OF DIABETES INVESTIGATION, 2024, 15 (06) : 704 - 706
  • [36] Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Tiwari, Atul
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1091 - 1104
  • [37] Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor - A case report
    Karthik, S.
    Joseph, P. E.
    Babu, T.
    JOURNAL OF POSTGRADUATE MEDICINE, 2019, 65 (04) : 244 - 246
  • [38] Saxagliptin A New Dipeptidyl Peptidase-4 Inhibitor for Type 2 Diabetes
    Lam, Sum
    Saad, Maha
    CARDIOLOGY IN REVIEW, 2010, 18 (04) : 213 - 217
  • [39] Metformin is a GLP-1 secretagogue, not a dipeptidyl peptidase-4 inhibitor
    Roy, R. Sinha
    Bergeron, R.
    Zhu, L.
    He, H.
    Jiang, G.
    Liu, F.
    Lyons, K.
    Pryor, K.
    Yao, J.
    Zhang, B. B.
    Thornberry, N.
    DIABETOLOGIA, 2007, 50 : S284 - S284
  • [40] Localized bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitor treatment
    Kazumasa Oya
    Masanao Fujii
    Shijima Taguchi
    Wataru Nishie
    Kentaro Izumi
    Hiroshi Shimizu
    European Journal of Dermatology, 2018, 28 : 250 - 251
12345